EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS
about
Development of autophagy inducers in clinical medicineMicroglia centered pathogenesis in ALS: insights in cell interconnectivityBACE1 across species: a comparison of the in vivo consequences of BACE1 deletion in mice and ratsAmyotrophic lateral sclerosis: a focus on disease progressionIncreased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs).Decreased Phosphorylated Protein Kinase B (Akt) in Individuals with Autism Associated with High Epidermal Growth Factor Receptor (EGFR) and Low Gamma-Aminobutyric Acid (GABA).Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease.Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice.
P2860
Q26822948-73482DBA-26B1-482B-96DA-63CBDACB0783Q27009559-70B7BA28-47AC-40EB-8AA9-A18DCA377CB0Q30361192-7F456B8F-92C4-427D-8D83-79CB06A293C9Q34064143-40CEB6D6-46FE-486D-A69D-79119367D8C0Q34203879-3E3B9EB1-A458-4D44-BB64-5F27ACD3079BQ36165457-3B20F45F-90D0-4E6F-B4F9-21C9282E36F7Q44597957-2C45571C-8089-4201-AD1D-86AABEE48F71Q54967456-0368FC90-3D71-4F03-921C-E468228A75EE
P2860
EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@ast
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@en
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@nl
type
label
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@ast
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@en
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@nl
prefLabel
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@ast
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@en
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@nl
P2093
P2860
P1433
P1476
EGFR inhibitor erlotinib delay ...... in the SOD1 mouse model of ALS
@en
P2093
Claire E Le Pichon
Hilda Solanoy
Kimberly Scearce-Levie
Nicholas Lewin-Koh
Ryan Watts
Sara L Dominguez
P2860
P304
P356
10.1371/JOURNAL.PONE.0062342
P407
P577
2013-01-01T00:00:00Z